Rare diseases
Investigational molecules
Locations
Switching to Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults with HIV-1: A Phase 3 Randomized Study
FranceStudy Comparing Doravirine/Lamivudine and Dolutegravir/Lamivudine for HIV Patients with Controlled Viral Load on Three-Drug Regimens
FranceStudy Comparing Doravirine and Dolutegravir-Based Treatments for People with HIV-1 Who Have Not Yet Started Therapy
FranceStudy on the Effectiveness of Doravirine, Tenofovir Disoproxil, and Lamivudine in HIV Patients with M184V/I Mutation and Controlled Viral Load
FranceA Study of Doravirine for Early Treatment of West Nile Virus Infection in Patients at Risk of Disease Worsening
ItalyStudy on Doravirine and Raltegravir for Maintaining Viral Control in HIV Patients with Low Viral Load
FranceStudy on Switching to Doravirine and Islatravir for People with HIV-1 on Antiretroviral Therapy
FranceStudy on HIV-1 Treatment for Patients New to Therapy: Comparing Doravirine/Islatravir with a Drug Combination
FranceStudy on Switching HIV Treatment to Doravirine and Islatravir for Patients with HIV-1
FranceStudy on Doravirine and Islatravir for People with HIV-1 Previously Treated with the Same Drug Combination
FinlandStudy Comparing Weekly Islatravir/Lenacapavir Regimen to Standard Care in HIV Patients with Controlled Viral Load
GermanyStudy on the Effectiveness of Doravirine and Dolutegravir for People with HIV Switching Antiretroviral Therapy
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
